ArticleNature communications2024

Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer.

M T Herrera-Abreu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.